On Tuesday, Northern Tier Energy LP (NYSE:NTI)’s shares inclined 1.28% to $26.17.
SuperAmerica is a part of the Northern Tier family of companies (NTI).
The Greater Metropolitan Automobile Dealers Association (GMADA), owners and operators of the Twin Cities Auto Show, has named SuperAmerica® as its presenting sponsor through 2020.
“This is a noteworthy partnership for us and reflects the Twin Cities Auto Show’s strong value in the community,” says Scott Lambert, executive vice president of GMADA. “The unique similarities between the Twin Cities Auto Show and SuperAmerica are guaranteed to enhance all areas of our businesses, counting discounts at the pump and in retail locations, raised awareness of the Auto Show, and our dedication to the community.”
Northern Tier Energy LP, an independent downstream energy company, engages in refining, retail, and pipeline operations in the United States. It operates through two segments, Refining and Retail. The Refining segment offers refined products, counting gasoline, diesel, jet fuel, and asphalt to resellers and consumers primarily in the Petroleum Administration for Defense District II region.
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)’s shares gained 2.79% to $5.16.
Catalyst Pharmaceuticals, Inc. (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, declared the appointment of Gary Ingenito, M.D., Ph.D, as Chief Medical Officer. Dr. Ingenito has more than 25 years of experience leading pharmaceutical development for drugs and biologics. In this new role, he will oversee all clinical development programs, medical affairs, regulatory and other related functions. Dr. Ingenito will report to Dr. Steven Miller, Catalyst’s Chief Operating Officer and Chief Scientific Officer. Following Dr. Ingenito’s joining Catalyst, the current Chief Medical Officer, Charles Gorodetzky, M.D., Ph.D, will continue to serve as a consultant to the company.
Catalyst Pharmaceuticals, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting rare (orphan) neurological diseases and disorders. The company offers Firdapse, a proprietary form of amifampridine phosphate, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome.
At the end of Tuesday’s trade, Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE)‘s shares surged 1.00% to $1.01.
Glancy Prongay & Murray LLP reminds investors of the forthcoming deadline in the class action complaint filed on behalf of a class comprising purchasers of the securities of Yingli Green Energy Holding, Co. (“Yingli” or the “Company”) (YGE) between March 18, 2014 and May 15, 2015, inclusive (the “Class Period”). Investors are encouraged to contact Glancy Prongay & Murray LLP preceding to the July 27, 2015 lead plaintiff deadline.
Yingli is one of the world’s largest solar panel producers, and operates on a high volume, low margin business model. Unbeknownst to investors the Company allegedly has overstated certain material accounting items, suffers severe liquidity problems, and may not be able to keep its production lines running in the near term.
Yingli Green Energy Holding Company Limited, together with its auxiliaries, designs, develops, markets, manufactures, sells, and installs photovoltaic (PV) products in the People’s Republic of China and internationally. The company offers polysilicon ingots and blocks, polysilicon wafers, PV cells, PV modules, and integrated PV systems; and develops and operates solar projects. It primarily sells its PV modules to distributors, wholesalers, power plant developers and operators, and PV system integrators under the brand names Yingli and Yingli Solar. Yingli Green Energy Holding Company Limited was founded in 1998 and is headquartered in Baoding, the People’s Republic of China.
PDC Energy Inc (NASDAQ:PDCE), ended its Tuesday’s trading session with 1.86% gain, and closed at $50.95.
PDC Energy, Inc. (PDCE) declared plans to host a conference call with investors to talk about 2015 second quarter results. Conference call materials will be accessible on the Company’s website, www.pdce.com, at the time of the call.
PDC Energy, Inc., an independent exploration and production company, acquires, explores for, develops, and produces crude oil, natural gas, and natural gas liquids in the United States. The company operates in two segments: Oil and Gas Exploration and Production, and Gas Marketing. The Oil and Gas Exploration and Production segment produces and sells natural gas to midstream service providers, marketers, and utilities; crude oil; and natural gas liquids.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
